Cancer research UK launches trial for potential new drug that could help immune system fight cancer


Cancer Research UK's Centre for Drug Development , in partnership with Amgen Inc., has launched a new clinical trial to test a drug that could stop a patient's immune system from protecting tumours. Cancer Research UK scientists are studying Amgen's experimental cancer drug, called AMG319, to find out if it removes the defence shield that hides cancer cells from the immune system.



from Biotech News